Anastrozole: Targeted Therapy for Hormone-Driven Breast Cancer

Anastrozole is a prescription medication primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It’s effective for early-stage treatment as well as first-line therapy for advanced or metastatic breast cancer, regardless of hormone receptor status. Additionally, it serves as a follow-up treatment for cases that have progressed despite tamoxifen use.
Since many breast tumors rely on estrogen to grow, anastrozole helps by reducing the body's estrogen production. By lowering estrogen levels, this therapy limits the hormone’s influence on tumor growth, making it a valuable tool in managing hormone-sensitive cancer.